Is anticoagulation superior in of the ESUS subgroups? #stroke #esus #meded Check out this meta-analysis of randomized controlled trials of ESUS patients investigating the efficacy of anticoagulation compared to antiplatelets based on various mechanisms. neurology.org/doi/10.1212/WN…

Mimics of medium or large vessel #vasculitis. *Seitz, L., Seitz, P., Pop, R. et al. Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases. Curr Rheumatol Rep 24, 352–370 (2022).

schematic of arterial supply of the Internal Capsule DOI:10.1016/j.cnp.2022.07.001 #stroke #neurotwitter #strokemed

Day 1 Clinical trial #WSC2024 Balloon Guide catheter trial stopped earlier and primary stroke prevention trial #stroke World Stroke Org

Starting DOAC within 4 days after stroke is NOT inferior to delayed initiation after 7 days. OPTIMAS trial published in Lancet this morning #WSC2024

Day 2 Clinical Trials: Step towards non-gated single-phase cardiac-neck-brain CTA, OPTIMAS/CATALYST will change guidelines, early anticoagulation can be implemented more convincingly, BP reduction <130 is better for overall CVD reduction #WSC2024 World Stroke Org #stroke

🔥 CATALYST 🔥 👉🏻individual patient data meta analysis 👉🏻DOAC resumption after AIS 👉🏻early <4d vs late >=5d 👉🏻early 💊<1 outcome < AIS without >sICH #WSC2024 David Seiffge INTERNEURONA Shadi Yaghi @WorlStrokeOrg Luciano Sposato 🇦🇷🇨🇦

Day 3 Clinical Trials #WSC2024 World Stroke Org Intra-arterial TNK not helpful in posterior circulation stroke, more evidence for minimally invasive surgery for ICH, MRI was non-inferior to CTP based patient selection for EVT and DOACs safe but not efficacious in CVT #strokemed

Acompáñanos al taller de neurosonologia en el GSA/SIECV 2024 SIECV-IASO Alianza Joven Latinoamericana contra el ACV Alianza ACV Colombia Asociación Colombiana de Neurología

GSA/SIECV 2024 SIECV-IASO Alianza Joven Latinoamericana contra el ACV Lumni-ALATAC Alianza ACV Colombia Asociación Colombiana de Neurología

Similar to CRASH trials, 1) INTERACT 1 - Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage (Pilot Phase study) 2) INTERACT 2 - Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage (Main Phase study) 3) INTERACT 3 - Intensive Care Bundle with Blood

Check out our new scientific statement about ischemic stroke prevention in patients with AFib and recent ischemic stroke, TIA or ICH #stroke #neurocriticalcare #neurology #MedEd Luciano Sposato 🇦🇷🇨🇦

#MondayTip Key studies on #DOAC vs VKA in CVT 🧠Several observational studies and small but important RCTs have evaluated the efficacy and safety of DOACs as an alternative to VKAs in Cerebral Venous Thrombosis ✅Results support DOACs as a reasonable treatment option

The U.S. FDA has approved #TNKase (#Tenecteplase; Genentech) for the treatment of adults with acute #ischemic #stroke. TNKase was found to be noninferior to #Activase, and in safety analysis, TNKase and Activase demonstrated comparable rates of 24-hour symptomatic intracerebral

🎓New #IschemicStroke e-Learning module available! world-stroke-academy.org/courses/wso-ws… 👉Stroke care: from pre-hospital management to advanced treatment strategies Duration: 5 hours ✍ Complete the quiz and get your certificate of completion! #StrokeEducation #MedicalLearning

#Mondaytip ☝️After #ICH, patients aren't only at risk of recurrence but also IS👉especially w/AF After COCROACH metaanalysis, PRESTIGE-AF is the 1st large RCT to provide new data ⚖️Stroke prevention and bleeding risk remains critical Awaiting results from at least 2+ ongoing RCTs

Vea este proyecto en Universidad del Rosario: Caracterización de pacientes con encefalopatía posterior reversible (PRES) en dos instituciones en Bogotá, Colombia entre 2017 y 2023 pure.urosario.edu.co/es/projects/ch…

La Máquina de Maripolles de Wintergatan es un instrumento hecho a mano por el músico sueco Martin Molin, que utiliza 2000 bolitas de mármol para interpretar una melodía única.

Clinical Characterization and Predictors of Poor Outcome in Patients with Cerebral Venous Thrombosis: Experience from a Latin American Cohort - Journal of Stroke and Cerebrovascular Diseases strokejournal.org/article/S1052-…

#WSC2025 Late breaking trials #TRIDENT Intensive BP control w/ a single ‘triple pill’: telmisartan 20mg+amlodipine 2.5mg+indapamide 1.25mg, for 2ry prevention after ICH 1670pts, ~58y, 33%female 1ry outcome, recurrent stroke: HR 0.61 p=0.017 NNT 27 👏👏 The George Institute for Global Health